非小細胞肺がん:グローバル医薬品市場(~2022)...市場調査レポートについてご紹介

【英文タイトル】PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 9
1.1 List of Tables 16
1.2 List of Figures 22
2 Introduction 24
2.1 Catalyst 24
2.2 Related Reports 25
2.3 Upcoming Related Reports 25
3 Disease Overview 26
3.1 Etiology and Pathophysiology 26
3.1.1 Etiology 26
3.1.2 Pathophysiology and Histology 26
3.1.3 NSCLC Biomarkers 27
3.1.4 Quality of Life 28
3.2 Symptoms 29
4 Epidemiology 31
4.1 Risk Factors and Comorbidities 32
4.1.1 Smokers are more likely to have lung cancer than non-smokers 33
4.1.2 Long-term exposure to radon increases the risk of lung cancer 35
4.1.3 Family history of any cancer increases lung cancer risk 35
4.1.4 TB increases the risk of lung cancer and increases mortality risk 35
4.1.5 COPD is a comorbidity that reduces lung cancer survival 36
4.1.6 Lung cancer screening programs may not be beneficial 36
4.1.7 Stage at diagnosis significantly impacts the survival of lung cancer cases 37
4.2 Global Trends 38
4.2.1 US 41
4.2.2 France 46
4.2.3 Germany 47
4.2.4 Italy 49
4.2.5 Spain 51
4.2.6 UK 53
4.2.7 Japan 54
4.2.8 China 56
4.2.9 India 58
4.3 Forecast Methodology 60
4.3.1 Sources Used 62
4.3.2 Sources Not Used 67
4.3.3 Forecast Assumptions and Methods 67
4.4 Epidemiology Forecast (2012-2022) 70
4.4.1 Incident/Prevalent Cases of NSCLC 70
4.4.2 Age-Specific Incident Cases of NSCLC 72
4.4.3 Sex-Specific Incident Cases of NSCLC 73
4.4.4 Age-Standardized Incidence Rates of NSCLC 75
4.4.5 Segmentation of NSCLC Incident Cases 76
4.5 Discussion 84
4.5.1 Limitations of the Analysis 85
4.5.2 Strengths of the Analysis 86
5 Disease Management 87
5.1 Treatment Overview 87
5.1.1 Diagnosis 88
5.1.2 Clinical Staging 89
5.1.3 Screening and Early Detection 91
5.1.4 Localized Procedures and Therapies 92
5.1.5 Systemic Chemotherapy 93
5.1.6 Targeted Therapy 93
5.2 US 96
5.2.1 Diagnosis 96
5.2.2 Clinical Practice 96
5.3 France 98
5.3.1 Diagnosis 98
5.3.2 Clinical Practice 99
5.4 Germany 100
5.4.1 Diagnosis 100
5.4.2 Clinical Practice 101
5.5 Italy 103
5.5.1 Diagnosis 103
5.5.2 Clinical Practice 104
5.6 Spain 105
5.6.1 Diagnosis 105
5.6.2 Clinical Practice 105
5.7 UK 106
5.7.1 Diagnosis 106
5.7.2 Clinical Practice 107
5.8 Japan 108
5.8.1 Diagnosis 108
5.8.2 Clinical Practice 109
5.9 China 110
5.9.1 Diagnosis 110
5.9.2 Clinical Practice 111
5.10 India 112
5.10.1 Diagnosis 112
5.10.2 Clinical Practice 112
6 Competitive Assessment 115
6.1 Overview 115
6.2 Strategic Competitor Assessment 116
6.3 Product Profiles – Major Brands, Chemotherapies 118
6.3.1 Alimta (pemetrexed disodium) 118
6.3.2 Abraxane (nab-paclitaxel) 123
6.4 Product Profiles – Major Brands, Targeted Therapies 127
6.4.1 Avastin (bevacizumab) 127
6.4.2 Gilotrif (afatinib) 132
6.4.3 Iressa (gefitinib) 138
6.4.4 Tarceva (erlotinib hydrochloride) 143
6.4.5 Xalkori (crizotinib) 149
7 Opportunity and Unmet Need 156
7.1 Overview 156
7.2 Improved Overall Survival and Less Toxicity 157
7.3 Treatments for Patients with Acquired TKI Resistance 158
7.4 Better Treatment Options for Squamous Patients 158
7.5 Preventing Relapse or Recurrence 159
7.6 More Efficacious Second-Line Therapies 159
7.7 Increased Availability of Mutation Testing 160
7.8 More Cost-Effective Therapies 160
7.9 Unmet Needs Gap Analysis 161
8 Pipeline Assessment 165
8.1 Overview 165
8.2 Clinical Trial Mapping 165
8.2.1 Clinical Trials by Country 165
8.3 Clinical Trials by Phase and Trial Status 167
8.4 Promising Drugs in Clinical Development 168
8.4.1 Onartuzumab (MetMab) 172
8.4.2 Necitumumab (IMC-11F8) 177
8.4.3 Ramucirumab (IMC-1121B) 183
8.4.4 Custirsen (OGX-011) 188
8.4.5 Ganetespib (STA-9090) 194
8.4.6 Nintedanib (BIBF1120) 201
8.4.7 Dacomitinib (PF-00299804) 206
8.4.8 LDK378 (ceritinib) 211
8.4.9 Yervoy (ipilimumab) 217
8.4.10 Nivolumab (BMS936558) 222
8.4.11 MPDL3280A (RG7446) 230
8.4.12 GSK1572932A (MAGE-A3 Cancer Immunotherapy) 233
8.4.13 Halaven (eribulin mesylate) 237
9 Current and Future Players 243
9.1 Overview 243
9.2 Trends in Corporate Strategy 245
9.3 Company Profiles 246
9.3.1 Roche/Genentech 246
9.3.2 Pfizer 249
9.3.3 Bristol-Myers Squibb 251
9.3.4 Eli Lilly 254
9.3.5 Boehringer Ingelheim 257
9.3.6 Novartis 259
10 Market Outlook 261
10.1 Global Markets 261
10.1.1 Forecast 261
10.1.2 Drivers and Barriers – Global Issues 265
10.2 United States 269
10.2.1 Forecast 269
10.2.2 Key Events 273
10.2.3 Drivers and Barriers 274
10.3 France 277
10.3.1 Forecast 277
10.3.2 Key Events 281
10.3.3 Drivers and Barriers 282
10.4 Germany 284
10.4.1 Forecast 284
10.4.2 Key Events 288
10.4.3 Drivers and Barriers 289
10.5 Italy 291
10.5.1 Forecast 291
10.5.2 Key Events 295
10.5.3 Drivers and Barriers 295
10.6 Spain 297
10.6.1 Forecast 297
10.6.2 Key Events 300
10.6.3 Drivers and Barriers 301
10.7 United Kingdom 302
10.7.1 Forecast 302
10.7.2 Key Events 306
10.7.3 Drivers and Barriers 307
10.8 Japan 309
10.8.1 Forecast 309
10.8.2 Key Events 313
10.8.3 Drivers and Barriers 313
10.9 China 316
10.9.1 Forecast 316
10.9.2 Key Events 320
10.9.3 Drivers and Barriers 320
10.10 India 323
10.10.1 Forecast 323
10.10.2 Key Events 327
10.10.3 Drivers and Barriers 327
11 Appendix 329
11.1 Bibliography 329
11.2 Abbreviations 360
11.3 Methodology 365
11.4 Forecasting Methodology 365
11.4.1 Number of NSCLC Patients Currently Seeking Treatment 365
11.4.2 Percent Drug-Treated Patients 366
11.4.3 Drugs Included in Each Therapeutic Class 366
11.4.4 Launch and Patent Expiry Dates 367
11.4.5 General Pricing Assumptions 368
11.4.6 Individual Drug Assumptions 371
11.4.7 Generic Erosion 381
11.4.8 Pricing of Pipeline Agents 381
11.5 Physicians and Specialists Included in This Study 383
11.6 Survey of Prescribing Physicians 385
11.7 About the Authors 386
11.7.1 Authors 386
11.7.2 Epidemiologists 387
11.7.3 Global Head of Healthcare 388
11.8 About GlobalData 389
11.9 Disclaimer 389


【レポート販売概要】

■ タイトル:非小細胞肺がん:グローバル医薬品市場(~2022)
■ 英文:PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update
■ 発行日:2014年4月30日
■ 調査会社:GlobalData
■ 商品コード:GDHC002EPIDR
■ 調査対象地域:グローバル
  • ビデオゲームの世界市場
    The global market for video games represents a total of nearly 62bn€ in 2014 and we estimate a strong CAGR of 8.5% for the period 2014-2018. This study follows the development of key indicators for the sector over five years and makes an appraisal of the key segments: • Home consoles • Handheld consoles • Offline computer games • Online computer games • Smartphone Game Market • Tablet Game Market …
  • 統合ビル管理システム(IBMS)の世界市場2017-2021
    About Integrated Building Management SystemsThe global IBMS market is expected to record a high growth during the forecast period. Many buildings are expected to opt for integration of their BAS. Integrated systems aid facility managers and building personnel to effectively monitor and regulate operations using a single controller as opposed to individual and distinct controllers for automation so …
  • 化学物流の世界市場2016-2020
    About Logistics Logistics deals with the procurement, planning, and implementation of activities in the forward and reverse logistics chain of an organization. The chemical industry uses logistics for the management of the way resources are acquired, stored, and moved to different end-users. The use of logistics allows the chemical industry access to a continuous supply of organic and inorganic ch …
  • Goodrich Petroleum Corporation社の石油・ガス開発・生産動向及びコスト分析(2013年第4四半期)
    Goodrich Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Goodrich Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is a …
  • Cariprazine (大うつ病性障害):医薬品市場予測及び分析(~2023)
    Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries …
  • 世界の煙突掃除治療及び血栓除去装置市場:Global Atherectomy and Thrombectomy Devices Market 2014-2018
    TechNavio's analysts forecast the Global Atherectomy and Thrombectomy Devices market to grow at a CAGR of 9.36 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing prevalence of abdominal aortic aneurysm and peripheral artery disease. The Global Atherectomy and Thrombectomy Devices market has also been witnessing the increase in demand for …
  • 潜水艦用センサーの世界市場2016-2020
    About Submarine Sensors A submarine employs a comprehensive array of sensors consisting of a group of passive and active sonars to detect targets. Active sonar sensors record audible pings to generate echoes and reveal objects around the submarine. However, while doing so, active sonars can simultaneously reveal the submarine’s presence to the enemies. Therefore, the use of sonars is increasingly …
  • 航空宇宙及び軍事用補助動力装置(APU)のグローバル市場(2014 – 2019)
    This report provides an in-depth analysis of the global aerospace and military APU market. It provides information of the current trends in the market with respect to regions, countries, technologies, and applications market. It throws light on the current market trends, drivers, restraints, opportunities, and challenges faced in the market that will impact the growth of this market. It analyzes t …
  • 世界のテキーラ(アルコール飲料)市場
    About Tequila Tequila is a distilled beverage made from blue agave plant located in the Mexican city of Tequila. It usually has an alcohol content of 38-40 percent by volume. Tequila accounts for a very small share in the Global Alcohol industry; however, the demand for the tequila is rising rapidly. In 2013, the Global Tequila market was dominated by the US in terms of volume as well as revenue. …
  • 組織検査の世界市場:免疫組織化学、in situハイブリダイゼーション、デジタルパソロジー、ワークフロー管理、特殊染色法
    The global tissue diagnostics market is valued at USD 3,202.5 Million in 2015 and expected to reach USD 4,471.1 Million by 2020, at a CAGR of 6.9% from 2015 to 2020. A major driver for the growth of the tissue diagnostics industry is the increasing prevalence of cancer. On the other hand, the high degree of consolidation, stringent regulatory requirements, and lack of budgets are restraining the g …
  • 世界の小売産業におけるIoT市場
    Internet of Things (IoT) is significantly adopted in every process of retailing such as advertising and marketing, smart kiosks, vending machines, inventory management, and customer payments. . The fact that IoT is rapidly connecting with these retailing processes is due to increasing internet ubiquity, and emergence of cloud platform. The declining cost of sensors and RFID have also significantly …
  • 世界のHIV感染症治療薬パイプライン分析
    The discovery of HIV virus, which causes AIDS, dates back to more than 30 years. Currently, there are more than 30 drugs in the market which have been approved by the FDA for the treatment of HIV infection. Consequent to the introduction of retrovirals in 1996, HIV is not considered to be a death sentence anymore. The advancements in this field have led to new drugs being produced which have been …
  • 白金採鉱の世界市場(~2020)
    Global PGM reserves according to Timetric's global platinum report was 2.4 billion ounces in January 2015, with South Africa accounting for 91.4% of this total, followed by Zimbabwe, Russia and the US with 4.1%, 1.6% and 1.3% respectively. The Bushveld Igneous Complex in South Africa and the Great Dyke Mineral belt in Zimbabwe are two of the world’s largest sources of platinum.
  • マスク検査装置の世界市場2016-2020
    About the Mask Inspection Equipment Market The semiconductor market is shifting toward complex and miniaturized devices. Semiconductor device manufacturers need higher inspection sensitivity as they move toward lower node sizes (10nm and beyond). The migration will introduce complex structures and designs, as well as new materials. Mask inspection equipment is fab equipment that is used, before li …
  • 産業用UPS(無停電電源装置)のグローバル市場(2014-2018)
    About Industrial UPS A UPS system is an electrical appliance used to provide power backup to a load during a power breakdown. These UPS systems provide instantaneous power backup by ensuring continuous power supply from energy stored in batteries. UPS systems are widely deployed for continuous power supply in various industries such as the Data Center and IT, Chemical, and Food Processing industri …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。